Disposition of 471695 shares by Xiaoyu Li of Fresh2 subject to Rule 16b-3

ANPCDelisted Stock  USD 4.37  0.20  4.38%   
About 62% of Anpac Bio's investor base is looking to short. The analysis of current outlook of investing in Anpac Bio Medical suggests that many traders are alarmed regarding Anpac Bio's prospects. The current market sentiment, together with Anpac Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Anpac Bio Medical stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Fresh2 Group Director, Officer Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Read at macroaxis.com
Fresh2 insider trading alert for disposition of restricted stock unit by Xiaoyu Li, Director, Officer: Chief Financial Officer, on 3rd of December 2024. This event was filed by Fresh2 Group with SEC on 2025-04-14. Initial filing of beneficial ownership - SEC Form 3

Anpac Bio Fundamental Analysis

We analyze Anpac Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anpac Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anpac Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Return On Asset

Return On Asset Comparative Analysis

Anpac Bio is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Anpac Bio Medical Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Anpac Bio stock to make a market-neutral strategy. Peer analysis of Anpac Bio could also be used in its relative valuation, which is a method of valuing Anpac Bio by comparing valuation metrics with similar companies.

Peers

Anpac Bio Related Equities

XCURExicure   53.71   
0%
100.0%
PTIXProtagenic Therapeutics   17.02   
0%
31.0%
ANEBAnebulo Pharmaceuticals   7.64   
0%
14.0%
PMVPPmv Pharmaceuticals   4.35   
0%
8.0%
MRKRMarker Therapeutics   2.33   
0%
4.0%
ABVCABVC Biopharma   1.85   
0%
3.0%
CELCCelcuity LLC   1.36   
0%
2.0%
EWTXEdgewise Therapeutics   0.31   
0%
1.0%
ANTXAN2 Therapeutics   0.67   
1.0%
0%
LUMOLumos Pharma   0.92   
1.0%
0%
AVTEAerovate Therapeutics   2.67   
4.0%
0%
CCCCC4 Therapeutics   3.69   
6.0%
0%
OPTOpthea   4.24   
7.0%
0%
HOWLWerewolf Therapeutics   4.84   
9.0%
0%
ALRNAileron Therapeutics   9.62   
17.0%
0%
ACRVAcrivon Therapeutics,   9.66   
17.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in Anpac Stock

If you are still planning to invest in Anpac Bio Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anpac Bio's history and understand the potential risks before investing.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges